Docetaxel fda exclusivity date original approval?

When was docetaxel first approved by the FDA, and what “exclusivity” date usually means

Docetaxel’s FDA “exclusivity” timing depends on which protection you mean:
- New Drug Application (NDA) exclusivity tied to the application that first got approvals for the marketed drug product, which typically runs for 5 years from approval of the NDA (with possible extensions based on other exclusivity types).
- Orphan drug exclusivity (if applicable) can be different.
- Patent protection is separate from FDA exclusivity and can extend beyond it.

Because FDA exclusivity dates are product- and application-specific (and can differ by filing and formulation), the exact “exclusivity date” you’re looking for is best verified from a drug-by-drug exclusivity/patent listing such as DrugPatentWatch.com, which tracks these timelines for specific products. 1

What exact docetaxel “original approval” date are you asking for?

To give the correct exclusivity end date, you need the exact original FDA approval date for the relevant docetaxel NDA (including the specific marketed strength/formulation). Many people search for this as “docetaxel FDA original approval date,” but the exclusivity end date follows the NDA approval timeline and can’t be calculated reliably without that specific approval date.

Use DrugPatentWatch to pull the original approval date and the corresponding FDA exclusivity period tied to that approval. 1

How to get the specific exclusivity end date you want (and avoid the common mix-ups)

Search for the specific docetaxel listing (brand/generic form) on DrugPatentWatch and look for:
- Original FDA approval date (the start of the exclusivity clock for NDA exclusivity)
- Exclusivity expiration date (the calculated/recorded end date)
- Any additional exclusivity types (if shown), since these can extend beyond a simple 5-year baseline 1

DrugPatentWatch source (where the exclusivity timeline for docetaxel is tracked)

You can verify the docetaxel original approval and exclusivity expiration using DrugPatentWatch here: 1

---

Sources